Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05287958 · ClinicalTrials.gov registry record

Feasibility of an Electrical Impedance Tomography Device for Pulmonary Function Testing in ALS Patients

A clinical trial of ALS, sponsored by Beth Israel Deaconess Medical Center.

Completed
Registry status
58
Enrollment target
2
Study locations

NCT05287958 is a study of ALS that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 58 participants, below the 1,034-participant average among 19 other ALS trials with a reported enrollment target (94% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05287958, a study of ALS, has completed, sponsored by Beth Israel Deaconess Medical Center.

COMPLETED
Registry status
58 participants
Enrollment target
2
Study locations

Study Summary

This is an unblinded pilot study to investigate the technical feasibility of using an electrical impedance tomography device for noninvasive pulmonary function monitoring in ALS patients. The study will enroll patients with ALS in one cohort and healthy volunteers in a second cohort that will both undergo EIT imaging with the investigational device prior to and while performing a standard PFT procedure.

Conditions Studied

ALS

Interventions

  • DIAGNOSTIC_TEST EIT

Study Locations (2)

Massachusetts

  • Beth Israel Deaconess Medical Center - Boston

New Hampshire

  • Dartmouth-Hitchcock Medical Center - Lebanon

Trial Details

FieldValue
Enrollment Target 58 participants
Start Date 2021-07-15
Est. Completion 2023-09-20

Sponsor

Beth Israel Deaconess Medical Center

488 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05287958

The ClinicalTrials.gov registry entry for NCT05287958 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,034-participant average among 19 other ALS trials with a reported enrollment target (94% lower). The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with ALS appearing as the primary indexed condition, and to 1 intervention - of which EIT is the first listed.

NCT05287958 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Massachusetts, New Hampshire.

Frequently Asked Questions

What is clinical trial NCT05287958 about?

NCT05287958 is a clinical study titled "Feasibility of an Electrical Impedance Tomography Device for Pulmonary Function Testing in ALS Patients". This is an unblinded pilot study to investigate the technical feasibility of using an electrical impedance tomography device for noninvasive pulmonary function monitoring in ALS patients. The study will enroll patients with ALS in one cohort and healthy volunteers in a second cohort that will both u...

What is the current status of trial NCT05287958?

This trial is currently completed. The enrollment target is 58 participants. The study started on 2021-07-15. Estimated completion is 2023-09-20.

What conditions does trial NCT05287958 study?

This clinical trial studies the following conditions: ALS.

What interventions are being tested in trial NCT05287958?

The interventions under investigation include: EIT (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT05287958?

This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05287958 being conducted?

This trial has 2 study locations across Massachusetts, New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for ALS

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

ALS

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.